全球DNA與基因晶片市場

預計2030年全球DNA和基因晶片市場規模將達205億美元

全球DNA和基因晶片市場規模預計在2024年為114億美元，預計到2030年將達到205億美元，2024年至2030年的複合年成長率為10.3%。報告分析的細分市場之一－耗材市場，預期複合年成長率為10.2%，到分析期結束時規模將達到126億美元。測量設備市場在分析期間內的複合年成長率預計為10.5%。

美國市場預計將達到 29 億美元，中國市場複合年成長率將達到 13.8%

預計到2024年，美國的DNA和基因晶片市場規模將達29億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到48億美元，在2024-2030年的分析期間內，複合年成長率為13.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為6.7%和8.5%。在歐洲，預計德國市場的複合年成長率為7.8%。

全球 DNA 和基因晶片市場—主要趨勢和促進因素摘要

DNA 和基因晶片如何徹底改變基因研究和診斷？

DNA 晶片或基因晶片，也稱為 DNA 微陣列，透過實現對基因表現和基因突變的高通量分析，正在徹底改變基因研究和診斷。這些晶片含有附著在固體表面的數千個 DNA 序列，使研究人員能夠並行分析複雜的遺傳訊息並快速識別基因表現模式。這種能力徹底改變了基因組學、藥物基因組學和腫瘤學等領域，在這些領域，了解基因變異對於開發個人化醫療和標靶治療至關重要。 DNA 晶片使醫療保健提供者能夠識別與疾病相關的基因突變，從而對癌症、心臟病和遺傳疾病等疾病進行更準確的診斷和個人化治療。

除了臨床應用外，DNA和基因晶片在藥物研發中也發揮重要作用，使製藥公司能夠研究不同基因對藥物化合物的反應。這加速了潛在治療標靶的識別，從而縮短了開發時間和成本。在農業領域，基因晶片用於對植物進行基因分析，有助於提高作物產量和抗病能力。隨著個人化醫療需求的增加和基因研究的進步，DNA和基因晶片已成為許多科學和臨床領域必不可少的工具，能夠更快、更準確地分析複雜的基因數據。

哪些技術進步正在塑造 DNA 和基因晶片市場？

生物資訊、微型化和高密度微陣列領域的創新引領著這一發展方向。生物資訊工具使研究人員能夠分析基因晶片產生的大量遺傳數據，從而深入了解基因表現模式並識別與特定疾病相關的突變。這些工具支持複雜的分析，包括全基因組關聯研究 (GWAS)，從而擴展了我們對遺傳因素對健康和疾病影響的理解。微型化和高密度陣列的進步也提高了基因晶片的容量，使得數百萬個探針能夠被放置在單一晶片上，從而最大限度地提高數據輸出量並提高檢測準確性。

此外，次世代定序儀(NGS) 的發展及其與基因晶片的整合擴大了可檢測基因突變的範圍，提高了診斷準確性並支持個人化治療方案。晶片實驗室技術的創新進一步提高了基因晶片的易用性，使其更易於臨床應用。這些進步使醫療保健提供者能夠在照護端進行快速基因檢測，並及時提供重要疾病的診斷結果。隨著技術的不斷發展，DNA 和基因晶片正變得越來越強大、經濟實惠且實用，使得高精度基因分析能夠更大規模地實現。

為什麼DNA和基因晶片對於個人化醫療至關重要？

DNA 和基因晶片對於個人化醫療至關重要，因為它們能夠進行全面的基因分析，使醫療保健提供者能夠為個別患者量身定做治療方案。透過分析基因表現模式和檢測基因突變，基因晶片可以深入了解患者對特定藥物或療法的反應。例如，基因晶片可以識別癌症相關基因的突變，使腫瘤學家能夠根據患者獨特的基因圖譜選擇最有效的標靶治療。這種個人化方法可以改善治療效果，降低藥物不良反應的風險，進而提高病人安全性和照護品質。

除了癌症治療外，基因晶片還用於評估多種疾病的遺傳易感性，包括心血管疾病、糖尿病和精神疾病。利用這些資訊，醫療保健提供者可以根據個人風險因素制定預防保健計劃，使患者能夠更有效地管理自身健康。基因晶片能夠以低成本提供準確的基因訊息，從而擴大基因檢測的可及性，使更多患者更接近實現個人化醫療。隨著人們對個人化、數據主導醫療保健的日益關注，DNA和基因晶片正成為提供與個人基因圖譜相對應的有針對性、有效治療方案的重要工具。

推動 DNA 和基因晶片市場成長的因素是什麼？

DNA和基因晶片市場的成長受到多種因素的推動，包括個人化醫療需求的不斷成長、基因組學研究的進步以及基因檢測技術投資的不斷增加。隨著醫療保健朝向個人化治療方案邁進，DNA和基因晶片在實現精準基因分析、支援標靶治療和促進預防醫學方面發揮關鍵作用。生物資訊學和次世代定序(NGS) 的快速發展進一步推動了市場的發展，因為這些技術補充了基因晶片的功能，並能夠更準確地檢測基因突變。

基因組學研究資金的增加，以及醫療保健和製藥業對基因檢測的日益普及，也促進了市場的擴張。各國政府和私人機構正在投資基因組學計劃，以更好地了解疾病的遺傳因素，這推動了研究和臨床領域對高通量DNA晶片的需求。此外，消費者對基因檢測意識的不斷增強，也導致了直接面對消費者的基因檢測服務的增加，進一步推動了市場的成長。隨著技術的進步以及DNA和基因晶片在醫療保健、農業和研究領域的應用不斷擴展，預計市場將持續成長，並為各個領域提供創新和個人化的解決方案。

部分

產品（消耗品、設備）、應用（癌症診斷和治療、基因表現、基因分型、藥物發現、其他應用）、最終用途（學術和政府研究機構、醫院和診斷中心、生物技術和製藥公司、其他最終用途）

受訪公司範例

• Affymetrix Inc
• Agilent Technologies Inc.
• Applied Microarrays Inc.
• Arrayit Corp.
• Biomerieux SA
• Biometrix Technology Inc.
• Bioneer Corp.
• Canon Inc.
• Capitalbio Corp.
• Cytopathfinder Inc.
• Eurofins Mwg Operon
• Exiqon
• Genisphere LLC
• Greiner Bio-One
• Hitachi Ltd.
• Illumina Inc.
• Integrated Dna Technologies
• LC Sciences
• Life Technologies Corp.
• Lifegen Technologies
• Macrogen Inc.
• Microarrays Inc.
• NGK Insulators Ltd.
• Ocimum Biosolutions Ltd.
• Oxford Gene Technology
• Pamgene International BV
• Perkinelmer
• Promega Corp.
• Roche Nimblegen Inc.
• Samsung Electronics Co Ltd.
• Savyon Diagnostics Ltd.
• Scienion AG
• Sequenom Inc.
• Shanghai Biochip Co Ltd.
• Sigma-Aldrich
• Surmodics Inc.
• Thermo Fisher Scientific Inc.
• Toshiba Corp.
• Wafergen Biosystems Inc.

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global DNA and Gene Chip Market to Reach US$20.5 Billion by 2030

The global market for DNA and Gene Chip estimated at US$11.4 Billion in the year 2024, is expected to reach US$20.5 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.6 Billion by the end of the analysis period. Growth in the Instrumentation segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 13.8% CAGR

The DNA and Gene Chip market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 13.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 8.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Global DNA and Gene Chip Market - Key Trends & Drivers Summarized

How Are DNA and Gene Chips Revolutionizing Genetic Research and Diagnostics?

DNA and gene chips, also known as DNA microarrays, are transforming genetic research and diagnostics by enabling high-throughput analysis of gene expression and genetic mutations. These chips contain thousands of DNA sequences attached to a solid surface, allowing researchers to analyze complex genetic information in parallel and quickly identify patterns in gene expression. This capability has revolutionized fields like genomics, pharmacogenomics, and oncology, where understanding genetic variations is essential for developing personalized medicine and targeted therapies. With DNA chips, healthcare providers can identify genetic mutations linked to diseases, guiding more accurate diagnoses and customized treatments for conditions like cancer, heart disease, and hereditary disorders.

In addition to clinical applications, DNA and gene chips play a crucial role in drug discovery, enabling pharmaceutical companies to test how different genes react to drug compounds. This accelerates the identification of potential therapeutic targets, reducing both development time and costs. In agriculture, gene chips are used to analyze plant genetics, helping improve crop yields and resistance to disease. As demand for personalized medicine grows and genetic research advances, DNA and gene chips have become indispensable tools across a range of scientific and clinical fields, supporting faster, more precise analysis of complex genetic data.

What Technological Advancements Are Shaping the DNA and Gene Chip Market?

Technological advancements are significantly enhancing the capabilities and applications of DNA and gene chips, with innovations in bioinformatics, miniaturization, and high-density microarrays leading the way. Bioinformatics tools allow researchers to analyze vast amounts of genetic data generated by gene chips, providing insights into genetic expression patterns and identifying mutations linked to specific diseases. These tools support complex analyses, including genome-wide association studies (GWAS), which have broadened our understanding of genetic influences on health and disease. Miniaturization and advances in high-density arrays have also increased the capacity of gene chips, enabling them to house millions of probes on a single chip, thereby maximizing data output and improving test accuracy.

In addition, the development of next-generation sequencing (NGS) and integration with gene chips has expanded the range of detectable genetic variants, enhancing diagnostic accuracy and supporting personalized treatment planning. Innovations in lab-on-a-chip technology have further improved gene chip usability, making them more accessible in clinical settings. These advancements allow healthcare providers to conduct rapid genetic testing at the point of care, providing timely results for critical conditions. As technology continues to evolve, DNA and gene chips are becoming more powerful, affordable, and practical, making high-precision genetic analysis available on a larger scale.

Why Are DNA and Gene Chips Essential in Personalized Medicine?

DNA and gene chips are essential to personalized medicine because they allow for comprehensive genetic profiling, enabling healthcare providers to tailor treatments to individual patients. By analyzing gene expression patterns and detecting genetic mutations, gene chips provide insights into how a patient may respond to specific medications or treatments, which is particularly valuable in fields like oncology. For example, gene chips can identify mutations in cancer-related genes, guiding oncologists to select the most effective targeted therapies for patients based on their unique genetic profiles. This personalized approach improves treatment outcomes and reduces the risk of adverse drug reactions, enhancing patient safety and quality of care.

In addition to cancer treatment, gene chips are used to assess genetic predispositions to various conditions, including cardiovascular disease, diabetes, and mental health disorders. With this information, healthcare providers can create preventive care plans tailored to individual risk factors, helping patients manage their health more effectively. The ability of gene chips to provide precise genetic information at a lower cost has expanded access to genetic testing, bringing personalized medicine closer to reality for more patients. As the focus on personalized, data-driven healthcare grows, DNA and gene chips are becoming essential tools for delivering targeted, effective treatments that cater to individual genetic profiles.

What Is Driving Growth in the DNA and Gene Chip Market?

The growth in the DNA and gene chip market is driven by several factors, including the rising demand for personalized medicine, advancements in genomics research, and increased investment in genetic testing technology. As healthcare moves toward individualized treatment approaches, DNA and gene chips play a crucial role in enabling precise genetic analysis, supporting targeted therapies, and facilitating preventive care. The rapid advancement of bioinformatics and next-generation sequencing (NGS) has further propelled the market, as these technologies complement gene chip capabilities, allowing for more accurate detection of genetic variants.

Increased funding for genomics research and growing adoption of genetic testing in healthcare and pharmaceutical sectors are also contributing to market expansion. Governments and private organizations are investing in genomics projects to enhance understanding of genetic factors in disease, which drives demand for high-throughput DNA chips in research and clinical settings. Moreover, the growing awareness of genetic testing among consumers is leading to an increase in direct-to-consumer genetic testing services, further fueling market growth. As technology improves and applications for DNA and gene chips expand across healthcare, agriculture, and research, the market is expected to experience sustained growth, supporting innovative, personalized solutions in various fields.

SCOPE OF STUDY:

The report analyzes the DNA and Gene Chip market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Consumables, Instrumentation); Application (Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery, Other Applications); End-Use (Academic & Government Research Institutes, Hospitals & Diagnostic Centers, Biotech & Pharma Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Affymetrix Inc
• Agilent Technologies Inc.
• Applied Microarrays Inc.
• Arrayit Corp.
• Biomerieux SA
• Biometrix Technology Inc.
• Bioneer Corp.
• Canon Inc.
• Capitalbio Corp.
• Cytopathfinder Inc.
• Eurofins Mwg Operon
• Exiqon
• Genisphere LLC
• Greiner Bio-One
• Hitachi Ltd.
• Illumina Inc.
• Integrated Dna Technologies
• LC Sciences
• Life Technologies Corp.
• Lifegen Technologies
• Macrogen Inc.
• Microarrays Inc.
• NGK Insulators Ltd.
• Ocimum Biosolutions Ltd.
• Oxford Gene Technology
• Pamgene International B.V.
• Perkinelmer
• Promega Corp.
• Roche Nimblegen Inc.
• Samsung Electronics Co Ltd.
• Savyon Diagnostics Ltd.
• Scienion AG
• Sequenom Inc.
• Shanghai Biochip Co Ltd.
• Sigma-Aldrich
• Surmodics Inc.
• Thermo Fisher Scientific Inc.
• Toshiba Corp.
• Wafergen Biosystems Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • DNA and Gene Chip - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Demand for Genomic Research Drives Growth of DNA and Gene Chip Market in Personalized Medicine
  • Rising Prevalence of Genetic Disorders and Cancers Spurs Adoption of DNA and Gene Chips for Early Diagnosis
  • Advancements in Microarray Technology Improve Accuracy and Efficiency in DNA and Gene Chip Applications
  • Growing Focus on Personalized Medicine and Pharmacogenomics Enhances Demand for DNA and Gene Chips in Drug Development
  • Expansion of Precision Medicine Initiatives Globally Fuels Market for DNA and Gene Chips in Targeted Therapies
  • Increasing Application of DNA and Gene Chips in Oncology Research Expands Market for Cancer Diagnostics
  • Growth in Agricultural Biotechnology for Crop Improvement Drives Demand for DNA and Gene Chips in Agrigenomics
  • Emergence of Direct-to-Consumer Genetic Testing Increases Adoption of DNA and Gene Chips in Consumer Genomics
  • Rising Application of DNA and Gene Chips in Infectious Disease Research Expands Use in Pathogen Detection
  • Increased Focus on Biomarker Discovery in Research and Diagnostics Fuels Development of DNA and Gene Chip Solutions
  • Technological Advancements in Genomics and Bioinformatics Enhance Application and Accuracy of DNA and Gene Chips
  • Growing Role of DNA and Gene Chips in Neurogenetics for Early Diagnosis and Research in Neurological Disorders
  • Expansion of Next-Generation Sequencing (NGS) Capabilities Increases Use of DNA Chips in Genomic Analysis
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for DNA and Gene Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Instrumentation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Instrumentation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Biotech & Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Biotech & Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Academic & Government Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Academic & Government Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Diagnosis & Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Cancer Diagnosis & Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Cancer Diagnosis & Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Gene Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Gene Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Gene Expression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 37: World DNA and Gene Chip Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for DNA and Gene Chip by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for DNA and Gene Chip by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for DNA and Gene Chip by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for DNA and Gene Chip by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for DNA and Gene Chip by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • DNA and Gene Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by Product - Consumables and Instrumentation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for DNA and Gene Chip by Product - Consumables and Instrumentation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for DNA and Gene Chip by Product - Percentage Breakdown of Value Sales for Consumables and Instrumentation for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for DNA and Gene Chip by End-Use - Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for DNA and Gene Chip by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies, Other End-Uses, Academic & Government Research Institutes and Hospitals & Diagnostic Centers for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for DNA and Gene Chip by Application - Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for DNA and Gene Chip by Application - Percentage Breakdown of Value Sales for Cancer Diagnosis & Treatment, Gene Expression, Genotyping, Drug Discovery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION